SEROQUEL XR 300 mg/1
quetiapine · TABLET, EXTENDED RELEASE · H2-Pharma, LLC
No Recall History
Plain English
SEROQUEL XR is a tablet, extended release containing quetiapine at 300 mg/1, taken oral. Manufactured by H2-Pharma, LLC.
Key Facts
- Brand Name
- SEROQUEL XR
- Generic Name
- quetiapine
- NDC Code (Product)
61269-273- Manufacturer
- H2-Pharma, LLC
- Strength
- 300 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA022047
- Marketing Start
- 07/16/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is SEROQUEL XR used for?
SEROQUEL XR contains quetiapine. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is SEROQUEL XR a controlled substance?
SEROQUEL XR is not classified as a controlled substance by the DEA.
What is the generic name for SEROQUEL XR?
The generic name for SEROQUEL XR is quetiapine. There are 12 other brand versions of quetiapine.
What is the NDC code for SEROQUEL XR 300 mg/1?
The NDC (National Drug Code) for SEROQUEL XR 300 mg/1 is 61269-273, listed by H2-Pharma, LLC.
Other Quetiapine Brands
See all →- Quetiapine Fumarate ER400 mg/172189-483
- Quetiapine50 mg/172789-266
- Quetiapine200 mg/176420-518
- QUETIAPINE FUMARATE400 mg/116729-097
- Quetiapine fumarate100 mg/133342-101
- Quetiapine fumarate200 mg/133342-103
- Quetiapine Fumarate200 mg/134908-637
- Quetiapine Fumarate200 mg/150090-7471
- Quetiapine Extended Release300 mg/150228-383
- Quetiapine Fumarate300 mg/150268-634
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)